[Antiarrhythimic properties of ethmozine].
D031841:Aconitum / Q000037:antagonists & inhibitors*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001146:Arrhythmia, Sinus / Q000188:drug therapy*; D001145:Arrhythmias, Cardiac / Q000139:chemically induced / Q000517:prevention & control*; D001281:Atrial Fibrillation / Q000188:drug therapy; D005117:Cardiac Complexes, Premature / Q000188:drug therapy; D002415:Cats; D003331:Coronary Vessels / Q000601:surgery; D003864:Depression, Chemical; D004195:Disease Models, Animal; D004285:Dogs; D004558:Electric Stimulation; D004562:Electrocardiography; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008026:Ligation; D011342:Procainamide / Q000627:therapeutic use*; D011802:Quinidine / Q000627:therapeutic use*; D051381:Rats; D013268:Stimulation, Chemical; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D011802:Quinidine; D011342:Procainamide
O protivoaritmicheskikh svoĭstvakh etmozina.